22 January 2026
22 January 2026
The SonoMotion platform will be showcased at booth 1508 during the 2026 American Urological Association meeting.
The acquisition aims to establish Worldwide as an oncology-focused CRO and expand its global reach for clinical trials.
The designation applies to investigational therapies that target rare diseases affecting less than 200,000 people in the US.
The agreement covers at least 43 scanners, with an expected revenue exceeding $24m.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
